EGFR and Alzheimer disease: NRG1/ErbB-dependent modulation of synaptic plasticity in the hippocampus has been reported also in pathological contexts, as in animal models of neurological and psychiatric disorders, like Angelman’s syndrome (AS) and Alzheimer’s disease (AD).